Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Alan Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Alan Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 70 · Grade C

Alan Meds

Visit Alan Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 77 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Alan Meds a bad call — it's best for readers comparing prepaid and flexible treatment options who can confirm the full payment, state access and processing dates before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
74
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
82
Track Record
88
77
CoreAge RxBrief Score 94 · 77Alan Meds

Price, coverage & the tracker

CoreAge RxAlan Meds
Brief Score94/100 (A)77/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm full prepaid charge

Advertised $158/mo equivalent on two months paid upfront; full selected total and renewal need confirmation.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier observed from $158/month for compounded semaglutide

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm full prepaid charge

Advertised $325/mo equivalent on six months paid upfront; full selected total and renewal need confirmation.

Full price details

Compounded tirzepatide offered. Current medication quote unknown; earlier observed from $295/month for compounded tirzepatide

CoverageUS only; restrictions by state, confirmed at intakeCompounded semaglutide: 46 states and D.C.; excludes Alaska, Hawaii, Louisiana and Mississippi. Other programs require confirmation
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Alan Meds: Current full quotes require confirmation. The public semaglutide offer is a prepaid two-month promotion; the tirzepatide equivalent requires six months upfront. Earlier prices remain historical.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.